دواعي استعمال بوتاسيوم كلوريد 0.2% و دكستروز 5% محلول للحقن الوريدي

Sterile intravenous infusion solution of potassium chloride 0.2% w/v with dextrose 5%, 500 ml (rubber cap).

• Prevention and treatment of potassium depletion and/or hypokalaemia where water and carbohydrate supply is required because normal intake is restricted.electronic medicines compendium (emc), UK
• Source of water, electrolytes and calories.DailyMed (US National Library of Medicine)

• Post-marketing: anaphylactic/hypersensitivity reactions, hospital-acquired hyponatraemia, hyponatraemic encephalopathy, infusion-site reactions (pain, phlebitis), chills, pyrexia, cardiac arrest; frequency not known.معلومة عامة عن المادة الفعالة · electronic medicines compendium (emc), UK

• Hypersensitivity; hyperkalaemia; clinically significant hyperglycaemia; hyperchloraemia; severe renal insufficiency with oliguria/anuria; uncompensated cardiac failure; Addison's disease; uncompensated diabetes and other glucose intolerance, hyperosmolar coma, hyperlactataemia.معلومة عامة عن المادة الفعالة · electronic medicines compendium (emc), UK
• Known hypersensitivity to potassium chloride and/or dextrose; clinically significant hyperkalemia; clinically significant hyperglycemia.معلومة عامة عن المادة الفعالة · DailyMed (US National Library of Medicine)

• Glucose-containing fluids can become physiologically hypotonic after glucose metabolism and may cause hyponatraemia, including hyponatraemic encephalopathy, particularly with non-osmotic vasopressin release.معلومة عامة عن المادة الفعالة · electronic medicines compendium (emc), UK
• Hyperkalemia may result in cardiac arrhythmias; avoid in patients with or at risk of hyperkalemia.معلومة عامة عن المادة الفعالة · DailyMed (US National Library of Medicine)

• Intrapartum maternal IV glucose may cause fetal hyperglycaemia and metabolic acidosis and rebound neonatal hypoglycaemia; maternal electrolytes should be controlled regularly.معلومة عامة عن المادة الفعالة · electronic medicines compendium (emc), UK
• Appropriate administration during pregnancy is not expected to cause adverse developmental outcomes.معلومة عامة عن المادة الفعالة · DailyMed (US National Library of Medicine)
• Potassium is present in human breast milk; no data on effects of the product on the breastfed infant.معلومة عامة عن المادة الفعالة · DailyMed (US National Library of Medicine)

• Monitor fluid balance, serum glucose, sodium and other electrolytes before and during administration, especially with SIADH risk or vasopressin-agonist co-medication.معلومة عامة عن المادة الفعالة · electronic medicines compendium (emc), UK